Mohammad Salajegheh, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis, Inclusion Body | 11 | 2014 | 145 | 2.100 |
Why?
|
| Muscular Diseases | 5 | 2018 | 553 | 1.380 |
Why?
|
| Median Neuropathy | 1 | 2021 | 7 | 0.750 |
Why?
|
| Lipomatosis | 1 | 2021 | 112 | 0.680 |
Why?
|
| Hamartoma | 1 | 2021 | 235 | 0.630 |
Why?
|
| Motor Neuron Disease | 1 | 2018 | 97 | 0.590 |
Why?
|
| Muscle, Skeletal | 12 | 2014 | 4948 | 0.510 |
Why?
|
| Channelopathies | 1 | 2015 | 30 | 0.510 |
Why?
|
| Spinal Nerve Roots | 1 | 2015 | 121 | 0.470 |
Why?
|
| Porphyrias | 1 | 2014 | 57 | 0.470 |
Why?
|
| Dermatomyositis | 5 | 2013 | 258 | 0.460 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2013 | 542 | 0.410 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 2009 | 163 | 0.400 |
Why?
|
| Primary Health Care | 2 | 2018 | 4687 | 0.380 |
Why?
|
| Muscle Proteins | 3 | 2011 | 1154 | 0.370 |
Why?
|
| Electrodiagnosis | 3 | 2021 | 148 | 0.350 |
Why?
|
| Ubiquitins | 3 | 2013 | 366 | 0.350 |
Why?
|
| Autoantigens | 3 | 2013 | 891 | 0.350 |
Why?
|
| Myositis | 2 | 2010 | 271 | 0.340 |
Why?
|
| Muscle Weakness | 3 | 2021 | 412 | 0.330 |
Why?
|
| Muscle Cells | 1 | 2009 | 195 | 0.310 |
Why?
|
| Postpartum Period | 1 | 2015 | 1175 | 0.300 |
Why?
|
| Myotonia | 3 | 2013 | 18 | 0.290 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 925 | 0.280 |
Why?
|
| Lower Extremity | 1 | 2015 | 1202 | 0.270 |
Why?
|
| Microdissection | 4 | 2010 | 151 | 0.270 |
Why?
|
| Up-Regulation | 4 | 2013 | 4125 | 0.260 |
Why?
|
| Poliomyelitis | 1 | 2006 | 92 | 0.260 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 257 | 0.250 |
Why?
|
| Interferon Type I | 5 | 2013 | 562 | 0.250 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2019 | 303 | 0.230 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2022 | 1469 | 0.220 |
Why?
|
| Autoantibodies | 2 | 2013 | 2118 | 0.220 |
Why?
|
| Cytokines | 4 | 2013 | 7396 | 0.200 |
Why?
|
| Cell Nucleus | 1 | 2009 | 2910 | 0.180 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 11076 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2007 | 2612 | 0.170 |
Why?
|
| tau Proteins | 1 | 2009 | 2095 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 12973 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2007 | 2547 | 0.150 |
Why?
|
| Median Nerve | 1 | 2019 | 132 | 0.150 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 4758 | 0.150 |
Why?
|
| Immunoblotting | 2 | 2011 | 1646 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 4576 | 0.140 |
Why?
|
| Polymyositis | 3 | 2013 | 75 | 0.140 |
Why?
|
| Mexiletine | 2 | 2013 | 30 | 0.130 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2015 | 14 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2822 | 0.130 |
Why?
|
| 4-Aminopyridine | 1 | 2015 | 80 | 0.130 |
Why?
|
| Orphan Drug Production | 1 | 2015 | 48 | 0.120 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 161 | 0.120 |
Why?
|
| Lumbosacral Plexus | 1 | 2015 | 51 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 4580 | 0.120 |
Why?
|
| Proteomics | 4 | 2012 | 3848 | 0.110 |
Why?
|
| RNA, Messenger | 7 | 2010 | 12794 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9610 | 0.110 |
Why?
|
| Humans | 38 | 2022 | 761596 | 0.100 |
Why?
|
| Immunologic Factors | 2 | 2014 | 1590 | 0.100 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 233 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 495 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2013 | 221 | 0.100 |
Why?
|
| Interferon-beta | 2 | 2010 | 345 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2013 | 161 | 0.100 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2012 | 62 | 0.100 |
Why?
|
| Muscle Strength | 2 | 2013 | 624 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 4 | 2014 | 9177 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3779 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2022 | 15843 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2021 | 3551 | 0.090 |
Why?
|
| Sodium Channels | 2 | 2012 | 339 | 0.090 |
Why?
|
| Disease Management | 2 | 2018 | 2508 | 0.090 |
Why?
|
| B-Cell Activating Factor | 1 | 2010 | 115 | 0.090 |
Why?
|
| Sarcomeres | 2 | 2009 | 368 | 0.080 |
Why?
|
| HIV-1 | 1 | 2007 | 6863 | 0.080 |
Why?
|
| Congo Red | 1 | 2009 | 48 | 0.080 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2010 | 149 | 0.080 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2009 | 70 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2010 | 2747 | 0.080 |
Why?
|
| Electromyography | 1 | 2014 | 1394 | 0.080 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2009 | 107 | 0.080 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 445 | 0.080 |
Why?
|
| Choristoma | 1 | 2010 | 206 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 774 | 0.080 |
Why?
|
| Veterans | 1 | 2022 | 2649 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2009 | 281 | 0.070 |
Why?
|
| Germinal Center | 1 | 2010 | 380 | 0.070 |
Why?
|
| Enzymes | 1 | 2009 | 257 | 0.070 |
Why?
|
| Polyneuropathies | 1 | 2009 | 137 | 0.070 |
Why?
|
| Postpoliomyelitis Syndrome | 1 | 2007 | 7 | 0.070 |
Why?
|
| Genes, gag | 1 | 2007 | 55 | 0.070 |
Why?
|
| Cross Reactions | 1 | 2009 | 817 | 0.070 |
Why?
|
| Antibody Specificity | 1 | 2009 | 1060 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2010 | 852 | 0.070 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2007 | 44 | 0.070 |
Why?
|
| Complementarity Determining Regions | 1 | 2007 | 149 | 0.070 |
Why?
|
| Neurofilament Proteins | 1 | 2009 | 336 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2010 | 599 | 0.070 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2007 | 235 | 0.070 |
Why?
|
| Aged | 14 | 2021 | 169310 | 0.070 |
Why?
|
| Demyelinating Diseases | 1 | 2009 | 352 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2007 | 239 | 0.060 |
Why?
|
| Lasers | 1 | 2010 | 952 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2005 | 75 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 2 | 2009 | 3839 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 2467 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 974 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1251 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2013 | 1356 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 1756 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 1526 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1311 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 9032 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 545 | 0.060 |
Why?
|
| Male | 16 | 2021 | 360846 | 0.050 |
Why?
|
| Middle Aged | 15 | 2019 | 220921 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1742 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2014 | 8321 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2010 | 1608 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 1111 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 999 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5035 | 0.050 |
Why?
|
| Adult | 11 | 2019 | 221210 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2850 | 0.050 |
Why?
|
| Female | 15 | 2019 | 392705 | 0.050 |
Why?
|
| Antibodies | 1 | 2009 | 2418 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1833 | 0.050 |
Why?
|
| HIV Infections | 1 | 2007 | 17354 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6075 | 0.040 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 916 | 0.040 |
Why?
|
| Fatigue | 1 | 2007 | 1552 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2005 | 526 | 0.040 |
Why?
|
| Mass Spectrometry | 3 | 2013 | 2192 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1177 | 0.040 |
Why?
|
| Young Adult | 3 | 2014 | 59260 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4591 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14665 | 0.040 |
Why?
|
| Biopsy | 4 | 2009 | 6766 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2010 | 18966 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 58984 | 0.030 |
Why?
|
| Double-Blind Method | 4 | 2014 | 12341 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2007 | 4142 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 21355 | 0.030 |
Why?
|
| Meningioma | 1 | 2005 | 1218 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4176 | 0.030 |
Why?
|
| Interferon-alpha | 2 | 2010 | 921 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2005 | 1248 | 0.030 |
Why?
|
| Alleles | 1 | 2007 | 6864 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4352 | 0.030 |
Why?
|
| Immobilization | 1 | 2016 | 229 | 0.030 |
Why?
|
| Chromatography, Liquid | 2 | 2009 | 983 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2015 | 26202 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 145 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 166 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 243 | 0.030 |
Why?
|
| Activin Receptors, Type II | 1 | 2014 | 123 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 2079 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 241 | 0.030 |
Why?
|
| Myelitis, Transverse | 1 | 2013 | 40 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 29890 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 1898 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 30053 | 0.030 |
Why?
|
| Vacuoles | 1 | 2013 | 228 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2013 | 298 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 258 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 878 | 0.020 |
Why?
|
| Glioma | 1 | 2005 | 3455 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2016 | 1468 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3483 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2013 | 916 | 0.020 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.020 |
Why?
|
| Inflammation Mediators | 2 | 2009 | 1886 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 888 | 0.020 |
Why?
|
| Disease Progression | 2 | 2022 | 13510 | 0.020 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2010 | 112 | 0.020 |
Why?
|
| Seveso Accidental Release | 1 | 2009 | 2 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2254 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2010 | 169 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 283 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 174 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 233 | 0.020 |
Why?
|
| Paralysis, Hyperkalemic Periodic | 1 | 2008 | 5 | 0.020 |
Why?
|
| Calpain | 1 | 2009 | 146 | 0.020 |
Why?
|
| Actinin | 1 | 2009 | 163 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 163 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2010 | 779 | 0.020 |
Why?
|
| Gene Expression | 2 | 2011 | 7581 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 626 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 400 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 405 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1091 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2009 | 602 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 387 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2009 | 778 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1741 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2010 | 455 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2127 | 0.020 |
Why?
|
| International Cooperation | 1 | 2013 | 1422 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 774 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2007 | 163 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1835 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 694 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 419 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 951 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2019 | 5971 | 0.020 |
Why?
|
| Quality of Life | 3 | 2013 | 13367 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1699 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9420 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2008 | 1262 | 0.020 |
Why?
|
| Glycolysis | 1 | 2009 | 835 | 0.020 |
Why?
|
| Genome | 1 | 2013 | 1740 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 7593 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2012 | 4021 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39106 | 0.010 |
Why?
|
| Pedigree | 1 | 2012 | 4542 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 1844 | 0.010 |
Why?
|
| Placebo Effect | 1 | 2007 | 518 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6374 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2707 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2007 | 1395 | 0.010 |
Why?
|
| Artifacts | 1 | 2010 | 1911 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2919 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4740 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 2231 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2643 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 11904 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2014 | 64685 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6534 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.010 |
Why?
|
| Proteome | 1 | 2009 | 1862 | 0.010 |
Why?
|
| Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2979 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 80647 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 5073 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2010 | 4937 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4369 | 0.010 |
Why?
|
| Exercise | 1 | 2013 | 5890 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11530 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9542 | 0.010 |
Why?
|
| Brain | 1 | 2022 | 27121 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6032 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13446 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17635 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 4725 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81539 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10194 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41495 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 16592 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8710 | 0.000 |
Why?
|
| Animals | 2 | 2013 | 168475 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2010 | 23447 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 36426 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 88326 | 0.000 |
Why?
|